AlphaYouJM
Insider selling
John M. Evans sold $739K of Beam Therapeutics Inc. (BEAM) stock
John M. Evans, CEO of Beam Therapeutics Inc. (BEAM), sold 30,078 shares of BEAM stock worth $739K, per an SEC Form 4 filed Apr 6, 2026.
It was an open-market sale.
The trade happened on Apr 1, 2026, 5 days before it was made public.
BEAM has moved +4.3% since the trade date, from $24.22 to $25.26 (Sep 21, 2026 close).
- Traded
- Apr 1, 2026
- Disclosed
- Apr 6, 2026
- Filing delay
- 5 days
- Price since
- +4.3%
- Role
- CEO
- Source
- SEC Form 4
More BEAM insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.